speb/financial-data huggingface dataset:
XENE cash_flow (annual, 2024-12-31) — End Cash Position: 142712000.00
XENE cash_flow (annual, 2024-12-31) — Financing Cash Flow: 12130000.00
XENE cash_flow (annual, 2024-12-31) — Free Cash Flow: -184464000.00
XENE income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -1064000.00
XENE balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -1612000.00
XENE income_statement (annual, 2024-12-31) — General And Administrative Expense: 68904000.00
XENE balance_sheet (annual, 2024-12-31) — Gross PPE: 31681000.00
XENE income_statement (annual, 2024-12-31) — Interest Income: 41943000.00
XENE income_statement (annual, 2024-12-31) — Interest Income Non Operating: 41943000.00
XENE balance_sheet (annual, 2024-12-31) — Invested Capital: 754903000.00
XENE cash_flow (annual, 2024-12-31) — Investing Cash Flow: 165000000.00
XENE balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 127496000.00
XENE balance_sheet (annual, 2024-12-31) — Investments And Advances: 127496000.00
XENE cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 12083000.00
XENE cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 12083000.00
XENE balance_sheet (annual, 2024-12-31) — Leases: 9363000.00
XENE balance_sheet (quarterly, 2024-12-31) — Leases: 9363000.00
XENE balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 7646000.00
XENE balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 7646000.00
XENE balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 2748000.00
XENE balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 2748000.00
XENE cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 12083000.00
XENE cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 12083000.00
XENE cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: 745000.00
XENE income_statement (annual, 2024-12-31) — Net Income: -234330000.00
XENE income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -234330000.00
XENE income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -234330000.00
XENE income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -234330000.00
XENE income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -234330000.00
XENE cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -234330000.00
XENE income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -234330000.00
XENE income_statement (annual, 2024-12-31) — Net Interest Income: 41943000.00
XENE cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 168075000.00
XENE income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 41943000.00
XENE balance_sheet (annual, 2024-12-31) — Net PPE: 18217000.00
XENE cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -3075000.00
XENE balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 754903000.00
XENE balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 9666000.00
XENE balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 9666000.00
XENE balance_sheet (annual, 2024-12-31) — Non Current Prepaid Assets: 7496000.00
XENE income_statement (annual, 2024-12-31) — Normalized EBITDA: -275674000.00
XENE income_statement (annual, 2024-12-31) — Normalized Income: -233284088.00
XENE cash_flow (annual, 2024-12-31) — Operating Cash Flow: -181389000.00
XENE cash_flow (annual, 2024-12-31) — Operating Gains Losses: 745000.00
XENE income_statement (annual, 2024-12-31) — Operating Income: -279298000.00
XENE income_statement (annual, 2024-12-31) — Operating Revenue: 0.00
XENE balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 76416086.00
XENE balance_sheet (annual, 2024-12-31) — Other Current Assets: 6890000.00
XENE balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -1612000.00
XENE income_statement (annual, 2024-12-31) — Other Gand A: 68904000.00
XENE income_statement (annual, 2024-12-31) — Other Income Expense: -1064000.00
XENE cash_flow (annual, 2024-12-31) — Other Non Cash Items: 1254000.00
XENE balance_sheet (annual, 2024-12-31) — Other Properties: 11631000.00
XENE balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 484193000.00
XENE balance_sheet (annual, 2024-12-31) — Payables: 10756000.00
XENE balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 24293000.00
XENE balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 9928000.00
XENE income_statement (annual, 2024-12-31) — Pretax Income: -238419000.00
XENE cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 47000.00
XENE balance_sheet (annual, 2024-12-31) — Properties: 0.00
XENE cash_flow (annual, 2024-12-31) — Purchase Of Investment: -532268000.00
XENE cash_flow (annual, 2024-12-31) — Purchase Of PPE: -3075000.00
XENE balance_sheet (annual, 2024-12-31) — Receivables: 1469000.00
XENE income_statement (annual, 2024-12-31) — Reconciled Depreciation: 2560000.00
XENE income_statement (annual, 2024-12-31) — Research And Development: 210394000.00
XENE balance_sheet (annual, 2024-12-31) — Retained Earnings: -899470000.00
XENE cash_flow (annual, 2024-12-31) — Sale Of Investment: 700343000.00
XENE income_statement (annual, 2024-12-31) — Selling General And Administration: 68904000.00
XENE balance_sheet (annual, 2024-12-31) — Share Issued: 76416086.00
XENE cash_flow (annual, 2024-12-31) — Stock Based Compensation: 50717000.00
XENE balance_sheet (annual, 2024-12-31) — Stockholders Equity: 754903000.00
XENE balance_sheet (annual, 2024-12-31) — Tangible Book Value: 754903000.00
XENE income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -18088.00
XENE income_statement (annual, 2024-12-31) — Tax Provision: -4089000.00
XENE income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.02
XENE balance_sheet (annual, 2024-12-31) — Total Assets: 798139000.00
XENE balance_sheet (annual, 2024-12-31) — Total Capitalization: 754903000.00
XENE balance_sheet (annual, 2024-12-31) — Total Debt: 9015000.00
XENE balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 754903000.00
XENE income_statement (annual, 2024-12-31) — Total Expenses: 279298000.00
XENE balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 43236000.00
XENE balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 162875000.00
XENE balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 7646000.00
XENE income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -279298000.00
XENE balance_sheet (annual, 2024-12-31) — Total Tax Payable: 5686000.00
XENE income_statement (annual, 2024-12-31) — Total Unusual Items: -1064000.00
XENE income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -1064000.00
XENE cash_flow (annual, 2024-12-31) — Unrealized Gain Loss On Investment Securities: 0.00
XENE cash_flow (quarterly, 2024-12-31) — Unrealized Gain Loss On Investment Securities: 0.00
XENE balance_sheet (annual, 2024-12-31) — Working Capital: 599674000.00
XENE income_statement (quarterly, 2025-03-31) — +Operating Expense: 80238000.00
XENE income_statement (quarterly, 2025-03-31) — +Total Revenue: 7500000.00
XENE balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 6882000.00
XENE balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 8649000.00
XENE balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 208460000.00
XENE balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 141498000.00
XENE income_statement (quarterly, 2025-03-31) — Basic Average Shares: 78687503.00
XENE income_statement (quarterly, 2025-03-31) — Basic EPS: -0.83
XENE cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 142712000.00
XENE balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 7617000.00
XENE cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -43000.00
XENE balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 8675000.00
XENE balance_sheet (quarterly, 2025-03-31) — Capital Stock: 1460850000.00
XENE balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 116657000.00
XENE balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 549629000.00
XENE cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 1151000.00
XENE cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 34510000.00
XENE cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -61652000.00
XENE cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -307000.00
XENE cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -3783000.00
XENE cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -926000.00
XENE cash_flow (quarterly, 2025-03-31) — Change In Receivables: -7178000.00
XENE cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -12194000.00
XENE cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -7178000.00
XENE cash_flow (quarterly, 2025-03-31) — Changes In Cash: -25991000.00
XENE balance_sheet (quarterly, 2025-03-31) — Common Stock: 1460850000.00
XENE balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 703957000.00
XENE cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 0.00
XENE balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 12160000.00
XENE balance_sheet (quarterly, 2025-03-31) — Current Assets: 565537000.00
XENE balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 1382000.00
XENE balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 1382000.00
XENE balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 32030000.00
XENE cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: -1213000.00
XENE cash_flow (quarterly, 2025-03-31) — Deferred Tax: -1213000.00
XENE cash_flow (quarterly, 2025-03-31) — Depreciation: 659000.00
XENE cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 659000.00
XENE cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 659000.00
XENE income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 78687503.00
XENE income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.83
XENE income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -65047000.00
XENE income_statement (quarterly, 2025-03-31) — EBIT: -72738000.00
XENE income_statement (quarterly, 2025-03-31) — EBITDA: -72079000.00
XENE cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: -64000.00
XENE cash_flow (quarterly, 2025-03-31) — End Cash Position: 116657000.00
XENE cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 1151000.00
XENE cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -61695000.00
XENE cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: 518000.00
XENE income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 35000.00
XENE balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -836000.00
XENE income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 19038000.00
XENE balance_sheet (quarterly, 2025-03-31) — Gross PPE: 17313000.00
XENE income_statement (quarterly, 2025-03-31) — Interest Income: 8083000.00
XENE income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 8083000.00
XENE balance_sheet (quarterly, 2025-03-31) — Invested Capital: 703957000.00
XENE cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 34510000.00
XENE balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 141498000.00
XENE balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 141498000.00
XENE cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 0.00
XENE balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 7293000.00
XENE balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 7293000.00
XENE cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
XENE cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 182000.00
XENE income_statement (quarterly, 2025-03-31) — Net Income: -65047000.00
XENE income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -65047000.00
XENE income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -65047000.00
XENE income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -65047000.00
XENE income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -65047000.00
XENE cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -65047000.00
XENE income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -65047000.00
XENE income_statement (quarterly, 2025-03-31) — Net Interest Income: 8083000.00
XENE cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 34553000.00
XENE income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 8083000.00
XENE balance_sheet (quarterly, 2025-03-31) — Net PPE: 17313000.00
XENE cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -43000.00
XENE balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 703957000.00
XENE balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 10879000.00
XENE balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 10879000.00
XENE balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 8053000.00
XENE income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -72114000.00
XENE income_statement (quarterly, 2025-03-31) — Normalized Income: -65076750.00
XENE cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -61652000.00
XENE cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 700000.00
XENE income_statement (quarterly, 2025-03-31) — Operating Income: -72738000.00
XENE income_statement (quarterly, 2025-03-31) — Operating Revenue: 7500000.00
XENE balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 76586359.00
XENE balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 7259000.00
XENE balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -836000.00
XENE income_statement (quarterly, 2025-03-31) — Other Gand A: 5531000.00
XENE income_statement (quarterly, 2025-03-31) — Other Income Expense: 35000.00
XENE cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 3269000.00
XENE balance_sheet (quarterly, 2025-03-31) — Other Properties: 9696000.00
XENE balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 432972000.00
XENE balance_sheet (quarterly, 2025-03-31) — Payables: 13441000.00
XENE balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 25601000.00
XENE balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 5047000.00
XENE income_statement (quarterly, 2025-03-31) — Pretax Income: -64620000.00
XENE cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 1151000.00
XENE balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
XENE cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -131239000.00
XENE cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -43000.00
XENE balance_sheet (quarterly, 2025-03-31) — Receivables: 8649000.00
XENE income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 659000.00
XENE income_statement (quarterly, 2025-03-31) — Research And Development: 61200000.00
XENE balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -964517000.00
XENE income_statement (quarterly, 2025-03-31) — Salaries And Wages: 13507000.00
XENE cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 165792000.00
XENE income_statement (quarterly, 2025-03-31) — Selling General And Administration: 19038000.00
XENE balance_sheet (quarterly, 2025-03-31) — Share Issued: 76586359.00
XENE cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 12174000.00
XENE balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 703957000.00
XENE balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 703957000.00
XENE income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 5250.00
XENE income_statement (quarterly, 2025-03-31) — Tax Provision: 427000.00
XENE income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.15
XENE balance_sheet (quarterly, 2025-03-31) — Total Assets: 743280000.00
XENE balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 703957000.00
XENE balance_sheet (quarterly, 2025-03-31) — Total Debt: 8675000.00
XENE balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 703957000.00
XENE income_statement (quarterly, 2025-03-31) — Total Expenses: 80238000.00
XENE balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 39323000.00
XENE balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 177743000.00
XENE balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 7293000.00
XENE income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -72738000.00
XENE balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 6559000.00
XENE income_statement (quarterly, 2025-03-31) — Total Unusual Items: 35000.00
XENE income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 35000.00
XENE balance_sheet (quarterly, 2025-03-31) — Working Capital: 533507000.00
XENE income_statement (quarterly, 2025-06-30) — +Operating Expense: 94229000.00
XENE income_statement (quarterly, 2025-06-30) — +Total Revenue: 0.00
XENE balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 4788000.00
XENE balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 1097000.00
XENE balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 213892000.00
XENE balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 137297000.00
XENE income_statement (quarterly, 2025-06-30) — Basic Average Shares: 78953445.00
XENE income_statement (quarterly, 2025-06-30) — Basic EPS: -1.07
XENE cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 116657000.00
XENE balance_sheet (quarterly, 2025-06-30) — Buildings And Improvements: 7290000.00
XENE cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -157000.00
XENE balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 8715000.00
XENE balance_sheet (quarterly, 2025-06-30) — Capital Stock: 1469196000.00
XENE balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 135381000.00
XENE balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 487545000.00
XENE cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 65000.00
XENE cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 82260000.00
XENE cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -64233000.00
XENE cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -318000.00
XENE cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 869000.00
XENE cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -5486000.00
XENE cash_flow (quarterly, 2025-06-30) — Change In Receivables: 7558000.00
XENE cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 2623000.00
XENE cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 7558000.00
XENE cash_flow (quarterly, 2025-06-30) — Changes In Cash: 18092000.00
XENE balance_sheet (quarterly, 2025-06-30) — Common Stock: 1469196000.00
XENE balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 633978000.00
XENE balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 16424000.00
XENE balance_sheet (quarterly, 2025-06-30) — Current Assets: 500252000.00
XENE balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 1459000.00
XENE balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 1459000.00
XENE balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 33047000.00
XENE cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -170000.00
XENE cash_flow (quarterly, 2025-06-30) — Deferred Tax: -170000.00
XENE cash_flow (quarterly, 2025-06-30) — Depreciation: 632000.00
XENE cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 632000.00
XENE cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 632000.00
XENE income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 78953445.00
XENE income_statement (quarterly, 2025-06-30) — Diluted EPS: -1.07
XENE income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -84706000.00
XENE income_statement (quarterly, 2025-06-30) — EBIT: -94229000.00
XENE income_statement (quarterly, 2025-06-30) — EBITDA: -93597000.00
XENE cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 632000.00
XENE cash_flow (quarterly, 2025-06-30) — End Cash Position: 135381000.00
XENE cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 65000.00
XENE cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -64390000.00
XENE cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: 0.00
XENE income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 1698000.00
XENE balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 113000.00
XENE income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 19244000.00
XENE balance_sheet (quarterly, 2025-06-30) — Gross PPE: 16495000.00
XENE income_statement (quarterly, 2025-06-30) — Interest Income: 7199000.00
XENE income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 7199000.00
XENE balance_sheet (quarterly, 2025-06-30) — Invested Capital: 633978000.00
XENE cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 82260000.00
XENE balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 137297000.00
XENE balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 137297000.00
XENE balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 7256000.00
XENE balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 7256000.00
XENE cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: -210000.00
XENE income_statement (quarterly, 2025-06-30) — Net Income: -84706000.00
XENE income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -84706000.00
XENE income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -84706000.00
XENE income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -84706000.00
XENE income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -84706000.00
XENE cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -84706000.00
XENE income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -84706000.00
XENE income_statement (quarterly, 2025-06-30) — Net Interest Income: 7199000.00
XENE cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 82417000.00
XENE income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 7199000.00
XENE balance_sheet (quarterly, 2025-06-30) — Net PPE: 16495000.00
XENE cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -157000.00
XENE balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 633978000.00
XENE balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 11049000.00
XENE balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 11049000.00
XENE balance_sheet (quarterly, 2025-06-30) — Non Current Prepaid Assets: 9188000.00
XENE income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -95295000.00
XENE income_statement (quarterly, 2025-06-30) — Normalized Income: -86391543.38
XENE cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -64233000.00
XENE cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -210000.00
XENE income_statement (quarterly, 2025-06-30) — Operating Income: -94229000.00
XENE income_statement (quarterly, 2025-06-30) — Operating Revenue: 0.00
XENE balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 76939811.00
XENE balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 11610000.00
XENE balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 113000.00
XENE income_statement (quarterly, 2025-06-30) — Other Gand A: 6014000.00
XENE income_statement (quarterly, 2025-06-30) — Other Income Expense: 1698000.00
XENE cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -2620000.00
XENE balance_sheet (quarterly, 2025-06-30) — Other Properties: 9205000.00
XENE balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 352164000.00
XENE balance_sheet (quarterly, 2025-06-30) — Payables: 6618000.00
XENE balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 23042000.00
XENE balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 8546000.00
XENE income_statement (quarterly, 2025-06-30) — Pretax Income: -85332000.00
XENE cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 65000.00
XENE balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
XENE cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -88816000.00
XENE cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -157000.00
XENE balance_sheet (quarterly, 2025-06-30) — Receivables: 1097000.00
XENE income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 632000.00
XENE income_statement (quarterly, 2025-06-30) — Research And Development: 74985000.00
XENE balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -1049223000.00
XENE income_statement (quarterly, 2025-06-30) — Salaries And Wages: 13230000.00
XENE cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 171233000.00
XENE income_statement (quarterly, 2025-06-30) — Selling General And Administration: 19244000.00
XENE balance_sheet (quarterly, 2025-06-30) — Share Issued: 76939811.00
XENE cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 13713000.00
XENE balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 633978000.00
XENE balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 633978000.00
XENE income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 12456.62
XENE income_statement (quarterly, 2025-06-30) — Tax Provision: -626000.00
XENE income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.01
XENE balance_sheet (quarterly, 2025-06-30) — Total Assets: 674281000.00
XENE balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 633978000.00
XENE balance_sheet (quarterly, 2025-06-30) — Total Debt: 8715000.00
XENE balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 633978000.00
XENE income_statement (quarterly, 2025-06-30) — Total Expenses: 94229000.00
XENE balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 40303000.00
XENE balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 174029000.00
XENE balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 7256000.00
XENE income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -94229000.00
XENE balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 1830000.00
XENE income_statement (quarterly, 2025-06-30) — Total Unusual Items: 1698000.00
XENE income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 1698000.00
XENE balance_sheet (quarterly, 2025-06-30) — Working Capital: 467205000.00
XENE income_statement (quarterly, 2025-09-30) — +Operating Expense: 96336000.00
XENE income_statement (quarterly, 2025-09-30) — +Total Revenue: 0.00
XENE balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 4554000.00
XENE balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 812000.00
XENE balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 223782000.00
XENE cash_flow (quarterly, 2025-09-30) — Amortization Of Securities: 177000.00
XENE balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 92988000.00
XENE income_statement (quarterly, 2025-09-30) — Basic Average Shares: 79247976.00
XENE income_statement (quarterly, 2025-09-30) — Basic EPS: -1.15
XENE cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 135381000.00
XENE balance_sheet (quarterly, 2025-09-30) — Buildings And Improvements: 6960000.00
XENE cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -281000.00
XENE balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 8327000.00
XENE balance_sheet (quarterly, 2025-09-30) — Capital Stock: 1475371000.00
XENE balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 104514000.00
XENE balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 462268000.00
XENE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 2360000.00
XENE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 38531000.00
XENE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -71752000.00
XENE cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -337000.00
XENE cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 5232000.00
XENE cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -3373000.00
XENE cash_flow (quarterly, 2025-09-30) — Change In Receivables: 283000.00
XENE cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 4963000.00
XENE cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 283000.00
XENE cash_flow (quarterly, 2025-09-30) — Changes In Cash: -30861000.00
XENE balance_sheet (quarterly, 2025-09-30) — Common Stock: 1475371000.00
XENE balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 559511000.00
XENE balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 20957000.00
XENE balance_sheet (quarterly, 2025-09-30) — Current Assets: 480137000.00
XENE balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 1495000.00
XENE balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 1495000.00
XENE balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 38335000.00
XENE cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: -701000.00
XENE cash_flow (quarterly, 2025-09-30) — Deferred Tax: -701000.00
XENE cash_flow (quarterly, 2025-09-30) — Depreciation: 641000.00
XENE cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 641000.00
XENE cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 641000.00
XENE income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 79247976.00
XENE income_statement (quarterly, 2025-09-30) — Diluted EPS: -1.15
XENE income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -90896000.00
XENE income_statement (quarterly, 2025-09-30) — EBIT: -96336000.00
XENE income_statement (quarterly, 2025-09-30) — EBITDA: -95695000.00
XENE cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -6000.00
XENE cash_flow (quarterly, 2025-09-30) — End Cash Position: 104514000.00
XENE cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 2360000.00
XENE cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -72033000.00
XENE cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: 89000.00
XENE income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: -89000.00
XENE balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 477000.00
XENE income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 19282000.00
XENE balance_sheet (quarterly, 2025-09-30) — Gross PPE: 15847000.00
XENE cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 1645000.00
XENE income_statement (quarterly, 2025-09-30) — Interest Income: 6206000.00
XENE income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 6206000.00
XENE balance_sheet (quarterly, 2025-09-30) — Invested Capital: 559511000.00
XENE cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 38531000.00
XENE balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 92988000.00
XENE balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 92988000.00
XENE balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 6832000.00
XENE balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 6832000.00
XENE cash_flow (quarterly, 2025-09-30) — Net Foreign Currency Exchange Gain Loss: -60000.00
XENE income_statement (quarterly, 2025-09-30) — Net Income: -90896000.00
XENE income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -90896000.00
XENE income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -90896000.00
XENE income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -90896000.00
XENE income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -90896000.00
XENE cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -90896000.00
XENE income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -90896000.00
XENE income_statement (quarterly, 2025-09-30) — Net Interest Income: 6206000.00
XENE cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 38812000.00
XENE income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 6206000.00
XENE balance_sheet (quarterly, 2025-09-30) — Net PPE: 15847000.00
XENE cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -281000.00
XENE balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 559511000.00
XENE balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 11750000.00
XENE balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 11750000.00
XENE balance_sheet (quarterly, 2025-09-30) — Non Current Prepaid Assets: 7114000.00
XENE income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -95606000.00
XENE income_statement (quarterly, 2025-09-30) — Normalized Income: -90820350.00
XENE cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -71752000.00
XENE cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 29000.00
XENE income_statement (quarterly, 2025-09-30) — Operating Income: -96336000.00
XENE income_statement (quarterly, 2025-09-30) — Operating Revenue: 0.00
XENE balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 77120168.00
XENE balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 17057000.00
XENE balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 477000.00
XENE income_statement (quarterly, 2025-09-30) — Other Gand A: 6715000.00
XENE income_statement (quarterly, 2025-09-30) — Other Income Expense: -89000.00
XENE cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 330000.00
XENE balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 3158000.00
XENE balance_sheet (quarterly, 2025-09-30) — Other Properties: 8887000.00
XENE balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 357754000.00
XENE balance_sheet (quarterly, 2025-09-30) — Payables: 4785000.00
XENE balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 25742000.00
XENE balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 11098000.00
XENE income_statement (quarterly, 2025-09-30) — Pretax Income: -90219000.00
XENE cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 2360000.00
XENE balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
XENE cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -74702000.00
XENE cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -281000.00
XENE balance_sheet (quarterly, 2025-09-30) — Receivables: 812000.00
XENE income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 641000.00
XENE income_statement (quarterly, 2025-09-30) — Research And Development: 77054000.00
XENE balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -1140119000.00
XENE income_statement (quarterly, 2025-09-30) — Salaries And Wages: 12567000.00
XENE cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 113514000.00
XENE income_statement (quarterly, 2025-09-30) — Selling General And Administration: 19282000.00
XENE balance_sheet (quarterly, 2025-09-30) — Share Issued: 77120168.00
XENE cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 13705000.00
XENE balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 559511000.00
XENE balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 559511000.00
XENE income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -13350.00
XENE income_statement (quarterly, 2025-09-30) — Tax Provision: 677000.00
XENE income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.15
XENE balance_sheet (quarterly, 2025-09-30) — Total Assets: 607836000.00
XENE balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 559511000.00
XENE balance_sheet (quarterly, 2025-09-30) — Total Debt: 8327000.00
XENE balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 559511000.00
XENE income_statement (quarterly, 2025-09-30) — Total Expenses: 96336000.00
XENE balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 48325000.00
XENE balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 127699000.00
XENE balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 9990000.00
XENE income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -96336000.00
XENE balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 231000.00
XENE income_statement (quarterly, 2025-09-30) — Total Unusual Items: -89000.00
XENE income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -89000.00
XENE balance_sheet (quarterly, 2025-09-30) — Working Capital: 441802000.00
XENE income_statement (annual, 2025-12-31) — +Operating Expense: 380570000.00
XENE income_statement (quarterly, 2025-12-31) — +Operating Expense: 109767000.00
XENE income_statement (annual, 2025-12-31) — +Total Revenue: 7500000.00
XENE income_statement (quarterly, 2025-12-31) — +Total Revenue: 0.00
XENE balance_sheet (annual, 2025-12-31) — Accounts Payable: 3885000.00
XENE balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 3885000.00
XENE balance_sheet (annual, 2025-12-31) — Accounts Receivable: 1371000.00
XENE balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 1371000.00
XENE balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -15449000.00
XENE balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -15449000.00
XENE balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 228234000.00
XENE balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 228234000.00
XENE cash_flow (annual, 2025-12-31) — Amortization Of Securities: 7369000.00
XENE cash_flow (quarterly, 2025-12-31) — Amortization Of Securities: 687000.00
XENE balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 37152000.00
XENE balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 37152000.00
XENE income_statement (annual, 2025-12-31) — Basic Average Shares: 79253751.00
XENE income_statement (quarterly, 2025-12-31) — Basic Average Shares: 80126081.00
XENE income_statement (annual, 2025-12-31) — Basic EPS: -4.36
XENE income_statement (quarterly, 2025-12-31) — Basic EPS: -1.31
XENE cash_flow (annual, 2025-12-31) — Beginning Cash Position: 142712000.00
XENE cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 104514000.00
XENE balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 6626000.00
XENE balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 6626000.00
XENE cash_flow (annual, 2025-12-31) — Capital Expenditure: -799000.00
XENE cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -318000.00
XENE balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 7944000.00
XENE balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 7944000.00
XENE balance_sheet (annual, 2025-12-31) — Capital Stock: 1598571000.00
XENE balance_sheet (quarterly, 2025-12-31) — Capital Stock: 1598571000.00
XENE balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 199163000.00
XENE balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 199163000.00
XENE balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 548886000.00
XENE balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 548886000.00
XENE cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 117113000.00
XENE cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 113537000.00
XENE cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 217998000.00
XENE cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 62697000.00
XENE cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -279118000.00
XENE cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -81481000.00
XENE cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: 1902000.00
XENE cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: 2864000.00
XENE cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 5511000.00
XENE cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 3193000.00
XENE cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -3157000.00
XENE cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 6628000.00
XENE cash_flow (annual, 2025-12-31) — Change In Receivables: 104000.00
XENE cash_flow (quarterly, 2025-12-31) — Change In Receivables: -559000.00
XENE cash_flow (annual, 2025-12-31) — Change In Working Capital: 4360000.00
XENE cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 8968000.00
XENE cash_flow (annual, 2025-12-31) — Changes In Account Receivables: 104000.00
XENE cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -559000.00
XENE cash_flow (annual, 2025-12-31) — Changes In Cash: 55993000.00
XENE cash_flow (quarterly, 2025-12-31) — Changes In Cash: 94753000.00
XENE balance_sheet (annual, 2025-12-31) — Common Stock: 1598571000.00
XENE balance_sheet (quarterly, 2025-12-31) — Common Stock: 1598571000.00
XENE balance_sheet (annual, 2025-12-31) — Common Stock Equity: 581760000.00
XENE balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 581760000.00
XENE cash_flow (annual, 2025-12-31) — Common Stock Issuance: 112151000.00
XENE balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 21602000.00
XENE balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 21602000.00
XENE balance_sheet (annual, 2025-12-31) — Current Assets: 560649000.00
XENE balance_sheet (quarterly, 2025-12-31) — Current Assets: 560649000.00
XENE balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 1532000.00
XENE balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 1532000.00
XENE balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 1532000.00
XENE balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 1532000.00
XENE balance_sheet (annual, 2025-12-31) — Current Liabilities: 41792000.00
XENE balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 41792000.00
XENE cash_flow (annual, 2025-12-31) — Deferred Income Tax: -3198000.00
XENE cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: -1114000.00
XENE cash_flow (annual, 2025-12-31) — Deferred Tax: -3198000.00
XENE cash_flow (quarterly, 2025-12-31) — Deferred Tax: -1114000.00
XENE cash_flow (annual, 2025-12-31) — Depreciation: 2543000.00
XENE cash_flow (quarterly, 2025-12-31) — Depreciation: 611000.00
XENE cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 2543000.00
XENE cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 611000.00
XENE cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 2543000.00
XENE cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 611000.00
XENE income_statement (annual, 2025-12-31) — Diluted Average Shares: 79253751.00
XENE income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 80126081.00
XENE income_statement (annual, 2025-12-31) — Diluted EPS: -4.36
XENE income_statement (quarterly, 2025-12-31) — Diluted EPS: -1.31
XENE income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -345910000.00
XENE income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -105261000.00
XENE income_statement (annual, 2025-12-31) — EBIT: -373070000.00
XENE income_statement (quarterly, 2025-12-31) — EBIT: -109767000.00
XENE income_statement (annual, 2025-12-31) — EBITDA: -370527000.00
XENE income_statement (quarterly, 2025-12-31) — EBITDA: -109156000.00
XENE cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 458000.00
XENE cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -104000.00
XENE cash_flow (annual, 2025-12-31) — End Cash Position: 199163000.00
XENE cash_flow (quarterly, 2025-12-31) — End Cash Position: 199163000.00
XENE cash_flow (annual, 2025-12-31) — Financing Cash Flow: 117113000.00
XENE cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 113537000.00
XENE cash_flow (annual, 2025-12-31) — Free Cash Flow: -279917000.00
XENE cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -81799000.00
XENE cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: 625000.00
XENE cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: 18000.00
XENE income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 1348000.00
XENE income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: -296000.00
XENE balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 335000.00
XENE balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 335000.00
XENE income_statement (annual, 2025-12-31) — General And Administrative Expense: 79632000.00
XENE income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 22068000.00
XENE balance_sheet (annual, 2025-12-31) — Gross PPE: 30796000.00
XENE balance_sheet (quarterly, 2025-12-31) — Gross PPE: 30796000.00
XENE income_statement (annual, 2025-12-31) — Interest Income: 26828000.00
XENE income_statement (quarterly, 2025-12-31) — Interest Income: 5340000.00
XENE income_statement (annual, 2025-12-31) — Interest Income Non Operating: 26828000.00
XENE income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 5340000.00
XENE balance_sheet (annual, 2025-12-31) — Invested Capital: 581760000.00
XENE balance_sheet (quarterly, 2025-12-31) — Invested Capital: 581760000.00
XENE cash_flow (annual, 2025-12-31) — Investing Cash Flow: 217998000.00
XENE cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 62697000.00
XENE balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 37152000.00
XENE balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 37152000.00
XENE balance_sheet (annual, 2025-12-31) — Investments And Advances: 37152000.00
XENE balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 37152000.00
XENE cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 112151000.00
XENE balance_sheet (annual, 2025-12-31) — Leases: 9407000.00
XENE balance_sheet (quarterly, 2025-12-31) — Leases: 9407000.00
XENE balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 6412000.00
XENE balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 6412000.00
XENE balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 6412000.00
XENE balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 6412000.00
XENE balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 2636000.00
XENE balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 2636000.00
XENE cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 112151000.00